Assignee
MOLECULAR GERIATRICS CORP
US·9 granted patents·2 pending applications·103 citations·filing 1994–2005
Top patents by PatentIndex Score
11 records- 0183US6864062B2Purified antigen for Alzheimer's disease and methods of obtaining and using sameMOLECULAR GERIATRICS CORP·Filed 2001·Granted Mar 8, 2005·22 cites·5 claims
- 0281US6214994B1Certain substituted 1-aryl-3-piperazin-1′-yl propanonesMOLECULAR GERIATRICS CORP·Filed 1999·Granted Apr 10, 2001·22 cites·3 claims
- 0376US5693804ASubstituted 1-aryl-3-piperazin-1'-yl propanonesMOLECULAR GERIATRICS CORP·Filed 1994·Granted Dec 2, 1997·17 cites·11 claims
- 0463US5658909ACertain substituted 1-aryl-3-piperazin-1'-yl propanones to treat Alzheimer's DiseaseMOLECULAR GERIATRICS CORP·Filed 1994·Granted Aug 19, 1997·23 cites·5 claims
- 0559US5705501ACertain substituted 1-aryl-3-morpholinopropanones to treat Alzheimer's DiseaseMOLECULAR GERIATRICS CORP·Filed 1994·Granted Jan 6, 1998·18 cites·6 claims
- 0651US7173132B2Certain substituted 1-aryl-3-piperazine-1′-yl propanonesMOLECULAR GERIATRICS CORP·Filed 2002·Granted Feb 6, 2007·0 cites·2 claims
- 0750US2005272094A1Purified antigen for Alzheimer's disease and methods of obtaining and using sameMOLECULAR GERIATRICS CORP·Filed 2005·Application pending·0 cites
- 0848US2004166536A1Method for predicting whether subjects with mild cognitive impairment (MCI) will develop Alzheimer's DiseaseMOLECULAR GERIATRICS CORP·Filed 2003·Application pending·0 cites
- 0935US6075026ACertain substituted 1-aryl-3-piperazin-1'-yl propanonesMOLECULAR GERIATRICS CORP·Filed 1997·Granted Jun 13, 2000·1 cites·1 claims
- 1032US6228878B1Methods for treating or preventing alzheimer's disease using substituted 2-aryl-3-morpholinopropanonesMOLECULAR GERIATRICS CORP·Filed 1999·Granted May 8, 2001·0 cites·2 claims
- 1131US6306857B1Methods for treating or preventing alzheimer's disease using substituted 1-aryl-3-piperazin-1′-yl propanonesMOLECULAR GERIATRICS CORP·Filed 1999·Granted Oct 23, 2001·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when MOLECULAR GERIATRICS CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →